Enterobacter spp
% resistance to ceftazidime by hospital
All clinical specimens
(January-June 2002)

WARDS
Hospital
Isolates
tested
% NS
% R
%I
GR051
2
 
 
 
GR026
18
11,11%
11,11%
0,00%
GR048
6
16,67%
16,67%
0,00%
GR012
17
17,65%
17,65%
0,00%
GR015
56
23,21%
23,21%
0,00%
GR008
8
25,00%
12,50%
12,50%
GR027
26
30,77%
30,77%
0,00%
GR043
16
31,25%
31,25%
0,00%
GR049
15
33,33%
26,67%
6,67%
GR032
8
37,50%
37,50%
0,00%
GR039
66
37,88%
37,88%
0,00%
GR033
20
40,00%
40,00%
0,00%
GR004
15
40,00%
40,00%
0,00%
GR007
12
41,67%
41,67%
0,00%
GR014
66
42,42%
37,88%
4,55%
GR030
41
46,34%
39,02%
7,32%
GR022
49
46,94%
44,90%
2,04%
GR001
16
50,00%
43,75%
6,25%
GR018
15
53,33%
53,33%
0,00%
GR013
18
55,56%
55,56%
0,00%
GR040
84
59,52%
58,33%
1,19%
GR005
35
60,00%
60,00%
0,00%
GR038
22
63,64%
63,64%
0,00%
GR050
68
64,71%
58,82%
5,88%
GR047
39
76,92%
74,36%
2,56%
GR042
27
77,78%
77,78%
0,00%
GR044
1
 
 
 
GR046
1
 
 
 
Grand Total
767
47,46%
45,37%
2,09%
  
 
 
 
 
Hospital Mean
 
43,33%
41,37%
1,96%
    
ICU
Isolates
tested
% NS
%R
%I
 
 
 
 
 
 
 
 
 
 
 
 
3
 
 
 
2
 
 
 
 
 
 
 
 
 
 
 
1
 
 
 
2
 
 
 
 
 
 
 
30
63,33%
63,33%
0,00%
6
66,67%
66,67%
0,00%
 
 
 
 
3
 
 
 
26
53,85%
53,85%
0,00%
6
83,33%
83,33%
0,00%
33
93,94%
93,94%
0,00%
4
 
 
 
 
 
 
 
 
 
 
 
32
84,38%
84,38%
0,00%
9
55,56%
55,56%
0,00%
 
 
 
 
 
 
 
 
6
83,33%
83,33%
0,00%
 
 
 
 
 
 
 
 
 
 
 
 
163
74,23%
74,23%
0,00%
 
 
 
 
 
73,05%
73,05%
0,00%